Gan & Lee Pharmaceuticals. (SHA: 603087)
China flag China · Delayed Price · Currency is CNY
48.42
-1.26 (-2.54%)
Nov 13, 2024, 3:00 PM CST

Gan & Lee Pharmaceuticals. Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Cash & Equivalents
3,5002,4432,8903,3062,825483.22
Upgrade
Short-Term Investments
--201.36276.44945.34201.62
Upgrade
Trading Asset Securities
1,5672,4101,6361,624787.051,058
Upgrade
Cash & Short-Term Investments
5,0674,8534,7285,2064,5571,743
Upgrade
Cash Growth
21.48%2.66%-9.20%14.24%161.45%47.94%
Upgrade
Accounts Receivable
271.39385.37189.57934.66827.35847.53
Upgrade
Other Receivables
4.07-0.990.160.964.68
Upgrade
Receivables
275.46385.37190.55934.82828.3852.21
Upgrade
Inventory
1,028860.51648.65651.33493.48471.35
Upgrade
Other Current Assets
117.8976.7397.3677.9580.5543.43
Upgrade
Total Current Assets
6,4886,1765,6646,8705,9603,110
Upgrade
Property, Plant & Equipment
3,8763,8863,6612,5952,1491,890
Upgrade
Long-Term Investments
523.28334.6630201.36466.05362.2
Upgrade
Other Intangible Assets
273.22278.08293.48295.99238.92131.85
Upgrade
Long-Term Deferred Tax Assets
165.06168.95138.2530.814.93-
Upgrade
Long-Term Deferred Charges
839.42821.97743.19588.87544.27474.85
Upgrade
Other Long-Term Assets
56.649.9976.51270.33134.6757.38
Upgrade
Total Assets
12,22211,71510,60710,8539,5076,027
Upgrade
Accounts Payable
111.0494.8236.5226.1514.7919.11
Upgrade
Accrued Expenses
167.51192.54190173.04183.07110.03
Upgrade
Current Portion of Leases
-2.185.695.07--
Upgrade
Current Income Taxes Payable
18.811.421.35106.3253.35137.44
Upgrade
Current Unearned Revenue
52.2652.9968.1336.5668.4490.69
Upgrade
Other Current Liabilities
457.06429.49511.36138.3990.19100.96
Upgrade
Total Current Liabilities
806.67773.45813.04485.53409.85458.22
Upgrade
Long-Term Leases
3.675.458.3312.17--
Upgrade
Long-Term Unearned Revenue
171.13179.63187.63141.98125.7771.07
Upgrade
Long-Term Deferred Tax Liabilities
21.86--36.1531.7825.91
Upgrade
Other Long-Term Liabilities
11.421412.2710.21.690.68
Upgrade
Total Liabilities
1,015972.521,021686.02569.09555.88
Upgrade
Common Stock
601.07594.16565.65561.54561.54360.9
Upgrade
Additional Paid-In Capital
-3,3512,5632,4762,47472.69
Upgrade
Retained Earnings
7,2526,8656,5257,1335,9055,035
Upgrade
Treasury Stock
-200.85-71.36-71.36---
Upgrade
Comprehensive Income & Other
3,5543.823.44-3.44-1.552.18
Upgrade
Total Common Equity
11,20710,7439,58610,1678,9395,471
Upgrade
Minority Interest
-0-0.16-0.16-0.16-0.16
Upgrade
Shareholders' Equity
11,20710,7439,58610,1678,9385,471
Upgrade
Total Liabilities & Equity
12,22211,71510,60710,8539,5076,027
Upgrade
Total Debt
3.677.6214.0117.24--
Upgrade
Net Cash (Debt)
5,0634,8464,7145,1894,5571,743
Upgrade
Net Cash Growth
22.08%2.80%-9.16%13.86%161.45%47.94%
Upgrade
Net Cash Per Share
8.598.558.379.258.553.45
Upgrade
Filing Date Shares Outstanding
618.18590.05561.54561.54561.54505.26
Upgrade
Total Common Shares Outstanding
618.18590.05561.54561.54561.54505.26
Upgrade
Working Capital
5,6825,4024,8516,3855,5502,652
Upgrade
Book Value Per Share
18.1318.2117.0718.1115.9210.83
Upgrade
Tangible Book Value
10,93410,4649,2929,8718,7005,339
Upgrade
Tangible Book Value Per Share
17.6917.7316.5517.5815.4910.57
Upgrade
Buildings
-1,3671,1651,0461,013841.37
Upgrade
Machinery
-1,4741,2371,2631,1711,014
Upgrade
Construction In Progress
-2,0072,003874.91410.12383.12
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.